Brain and Central Nervous System Tumors — Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
Citation(s)
A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors